

%201.webp)


%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)


%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Qatar does not have a publicly documented national pharmaceutical serialization and traceability system equivalent to Tatmeen, EMVS, or MDLP. The clearest published requirement identified is a GS1 based barcoding requirement tied to Hamad Medical Corporation, or HMC, tender and supply chain requirements, rather than a nationwide serial event reporting model managed by a central pharma traceability hub. (Hamad Medical Corporation)
Qatar has also established GS1 Qatar as the local GS1 member organization, which supports GTIN, GLN, and other GS1 identification standards used by companies operating in the market. (GS1 Qatar)
For HMC tender driven compliance, the published requirement identified is:
Based on the sources reviewed, serial number is not clearly published as a mandatory national requirement for all pharmaceutical packs in Qatar. The evidence located points more strongly to GTIN, batch, and expiry identification for HMC supply requirements
No official public source was found that requires routine national reporting of the following to a Qatar pharma traceability repository:
No official public source was identified that establishes a national central pharmaceutical reporting hub in Qatar for commission, aggregation, shipping, receiving, returns, or decommission reporting at serial level. The available published material points to:
As a result, current published requirements appear to be procurement and supply chain identification focused, not a publicly documented end to end national serial event repository. This is an evidence based conclusion from the sources reviewed. (Hamad Medical Corporation)
The clearest published requirement identified is at tertiary packaging level, where SSCC is used for higher level logistics identification in the HMC supply chain context.
However, no official public source was identified that mandates a national parent child aggregation reporting model for all pharmaceutical products across Qatar. In practice, companies supplying HMC should be prepared to support logistics level identification and traceability using SSCC.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.